Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Otsuka

Status and phase: Completed; Phase 3

Conditions: Alzheimer Disease

Treatments: Drug: aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00036114

CN138-004

Details and patient eligibility

About

The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.

Sex: All

Ages: 55 to 95 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Institutionalized patients with Alzheimer's